Search by Medical Condition
A B C D E F G H I J K L M N O P Q R S T U V W X Y ZClinical Trials for No-Reflow Phenomenon
- Rivaroxaban for Slow Coronary Flow After PCI in STEMI
- Oral Nicorandil for Prevention of No Reflow Phenomenon in Anterior STEMI Patients Undergoing PPCI
- The Investigator Administers Intracoronary Adrenaline Via the Catheter in STEMI Patients During Primary PCI, After Flow Restoration and Before Stenting, and Studies Its Effect in Prevention of No Reflow
- Empagliflozin for No-reflow Phenomenon in PCI for STEMI
- A Study to Evaluate the Impact of Pre-procedural Intracoronary Nicorandil Injection to PREVENT reductioN Of decREased TIMI FLOW in Patients Who Undergoing Percutaneous Coronary Intervention for the Coronary Artery Disease
- Alpha Lipoic Acid Effect on No-Reflow Phenomenon
- Adrenaline for the Treatment of No-Reflow in Normotensive Patients
- The EPIVER Randomized Controlled Trial
- Efficacy of Intracoronary Infusion of Different Medicine in STEMI Patients With CSFP
- Ticagrelor and Clopidogrel on Reperfusion in Patients With AMI
- Intracoronary Tirofiban on No-Reflow Phenomena